This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Control of the Malignant Hyperpyrexic Syndrome in MSH Swine by Dantrolene Sodium.Br. J. Anaesth. 1975; 47: 62
- Orally Administered Dantrolene for Prophylaxis of Malignant Hyperthermia.Anesthesiology. 1979; 50: 156
- Management of Suspected Malignant Hyperexia in an Infant.Anesth. Analg. 1979; 58: 33
Gallagher, D. M., and Hyer, R. L.: Dantrolene Administration in a Malignant Hyperthermia Susceptible Human. (Submitted for publication.)
- Dantrolene in Porcine Malignant Hyperthermia.Anesthesiology. 1976; 44: 488
- Porcine Malignant Hyperthermia.Anesthesiology. 1976; 44: 57
- Rationale for Dantrolene vs. Procainamide for Treament of Malignant Hyperthermia.Anesthesiology. 1979; 50: 118
- Evaluation of a Muscle Relaxant: Dantrolene Sodium (Dantrium).J. Am. Med. Assoc. 1975; 231: 862
© 1979 Published by Elsevier Inc.